Chakrabarti Sankha Shubhra, Bir Aritri, Poddar Jit, Sinha Maitrayee, Ganguly Anirban, Chakrabarti Sasanka
ICARE Institute of Medical Sciences and Research - Biochemistry, Haldia, India.
Curr Alzheimer Res. 2016;13(11):1232-1248. doi: 10.2174/1567205013666160603004239.
The metabolic turnover of sphingolipids produces several signaling molecules that profoundly affect the proliferation, differentiation and death of cells. In particular, an enormous body of information is available that defines the varied role of ceramide and sphingosine-1-phosphate in cell death and survival. This review specifically examines the role of ceramide and sphingosine-1- phosphate in triggering neuronal death in Alzheimer's disease by analyzing the data from post-mortem studies and experimental research. There is compelling evidence that ceramide plays a key role in the neurodegeneration and amyloidogenesis occurring in the brain in Alzheimer's disease. Further, it appears that ceramide and amyloid beta protein orchestrate an attack on mitochondria to set in the pathways of cell death. However, the complexity of metabolic and signaling pathways of sphingolipid derivatives precludes an immediate identification of effective drug targets for the therapy of Alzheimer's disease.
鞘脂的代谢转换产生多种信号分子,这些分子对细胞的增殖、分化和死亡有着深远影响。特别是,已有大量信息阐明了神经酰胺和1 -磷酸鞘氨醇在细胞死亡和存活中的不同作用。本综述通过分析尸检研究和实验研究的数据,专门探讨了神经酰胺和1 -磷酸鞘氨醇在引发阿尔茨海默病神经元死亡中的作用。有确凿证据表明,神经酰胺在阿尔茨海默病大脑中发生的神经退行性变和淀粉样蛋白生成过程中起关键作用。此外,神经酰胺和β淀粉样蛋白似乎协同攻击线粒体,从而启动细胞死亡途径。然而,鞘脂衍生物的代谢和信号通路十分复杂,这使得难以立即确定用于治疗阿尔茨海默病的有效药物靶点。